Skip to content

Clinical trials

Terminated Myelodysplastic Syndromes trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Status: Terminated Country / region: Australia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20142
20151
20182
20202
20213
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AbbVie1
Amgen1
Bristol-Myers Squibb1
Gilead Sciences1
Janssen Research & Development, LLC1
Kyntra Bio1
Sanofi1
Servier Bio-Innovation LLC1
TetraLogic Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes13
Leukemia, Myeloid, Acute4
Leukemia, Myelomonocytic, Chronic3
Anemia1
Anemia, Refractory, with Excess of Blasts1
Leukemia1
Lymphatic Diseases1
Lymphoma, Non-Hodgkin1
Multiple Myeloma1
Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.